Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-04

Clinical Trial Update: A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial update reports completed results for a new Allergan therapy in diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allergan experimental therapy for diabetic macular edema

Snippet

Sponsor: Allergan | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2014-08-04